![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2005, Cold Spring Harbor Laboratory Press Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: A tool for identifying differentially regulated genes 1 Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z4 2 Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada V5A 1S6 3Corresponding author. E-mail bob/at/cmdr.ubc.ca; fax (604) 827-5566. Received November 29, 2004; Accepted January 24, 2005. This article has been cited by other articles in PMC.Abstract Pseudomonas aeruginosa is a major cause of nosocomial (hospital-derived) infections, is the predominant pathogen in chronic cystic fibrosis lung infections, and remains difficult to treat due to its high intrinsic antibiotic resistance. The completion of the P. aeruginosa PAO1 genome sequence provides the opportunity for genome-wide studies to increase our understanding of the pathogenesis and biology of this important pathogen. In this report, we describe the construction of a mini-Tn5-luxCDABE mutant library and a high-throughput inverse PCR method to amplify DNA flanking the site of insertion for sequencing and insertion site mapping. In addition to producing polar knockout mutations in nonessential genes, the promoterless luxCDABE reporter present in the transposon serves as a real-time reporter of gene expression for the inactivated gene. A total of 2519 transposon insertion sites were mapped, 77% of which were nonredundant insertions. Of the insertions within an ORF, -55% of total and unique insertion sites were transcriptional luxCDABE fusions. A bias toward low insertion-site density in the genome region that surrounds the predicted terminus of replication was observed. To demonstrate the utility of chromosomal lux fusions, we performed extensive regulatory screens to identify genes that were differentially regulated under magnesium or phosphate limitation. This approach led to the discovery of many known and novel genes necessary for these environmental adaptations, including genes involved in resistance to cationic antimicrobial peptides. This dual-purpose mutant library allows for functional and regulation studies and will serve as a resource for the research community to further our understanding of P. aeruginosa biology. Genome-wide mutant libraries are collections of isogenic mutants in nonessential genes and are a powerful tool to understand the biology of an organism. Mutant libraries have been constructed systematically in Escherichia coli and Bacillus subtilis (Kobayashi et al. 2003; Kang et al. 2004) or by random transposon mutagenesis in Neisseria meningitidis, Mycoplasma, Pseudomonas aeruginosa, Helicobacter pylori, and the yeast Saccharomyces cerevisiae (Hutchison et al. 1999; Geoffroy et al. 2003; Jacobs et al. 2003; Salama et al. 2004; Scherens and Goffeau 2004). Saturating mutagenesis strategies enable the recovery of mutants in all nonessential genes, and therefore provide an estimate for the number of essential genes. In addition, mutant libraries allow the characterization of many known and unknown genes by standard phenotypic screening. Mutants can be generated with additional properties, depending on the features of the transposon used. For example, the transposon can encode a variety of promoterless reporter genes (phoA, lacZ, gfp, lux) to generate transcriptional or translational fusions to the inactivated gene. Transposons may contain outward-facing, inducible promoters that avoid polar mutations and permit identification of essential genes under noninducing conditions (Judson and Mekalanos 2000). Also, the presence of recombination sites within the transposon permits the use of epitope or hexahistidine tags for protein localization studies or protein purification, respectively (Ross-Macdonald et al. 1999; Jacobs et al. 2003). P. aeruginosa is the primary cause of chronic lung infections in cystic fibrosis patients, one of the most frequently isolated pathogens from nosocomial infections and poses problems for immunocompromised AIDS and cancer patients (Govan and Deretic 1996; Quinn 1998; Hancock and Speert 2000). P. aeruginosa initiates infections at mucosal surfaces, but has the capacity to become invasive and therefore is frequently isolated from the lung, wounds, urinary tract, and blood. Infections are difficult to treat due to the high intrinsic antibiotic resistance of this organism attributed to low outer membrane permeability coupled with additional resistance mechanisms, such as active drug efflux and antibiotic modification (Hancock and Speert 2000). In addition to being a prominent human pathogen, P. aeruginosa is pathogenic to plants, animals, nematodes, and insects, and is therefore an excellent model for host–pathogen interaction studies, given the variety of experimental infection models (Hendrickson et al. 2001). Between the original manual PAO1 genome annotation (http://www.pseudomonas.com) (Stover et al. 2000) and a subsequent reannotation (Weinel et al. 2003), up to 75% of the 5570 ORFs have been assigned probable functions. The aim of this research was to generate a library of multifunctional mutants that could be used for further studies to ultimately increase our understanding of the function of those genes that remain uncharacterized. We demonstrate the utility of this library by identifying differentially regulated genes from bacteria grown under magnesium and phosphate limitation and using this information to establish functions for selected genes involved in cationic antimicrobial peptide (CAP) resistance. Results and Discussion Mini-Tn5-lux transposon mutagenesis Random mini-Tn5 transposon mutagenesis was used to generate mutants in P. aeruginosa PAO1. The mini-Tn5 derivative used contains the inner and outer transposase recognition sequences flanking a promoterless luxCDABE operon and a tetracycline (Tc) resistance cassette (Winson et al. 1998). This transposon was selected because insertion into a gene results in a knockout mutation and may lead to the production of a transcriptional luxCDABE fusion. The bioluminescence lux reporter is ideal for high-throughput gene expression studies because of the ability to monitor light production in real-time without the addition of enzyme substrates. All transposon insertions result in polar mutations of downstream genes in the same operon, due to the presence of transcriptional and translational termination signals that flank the tetracycline resistance marker. The total library consisted of -18,500 randomly picked mutants without discriminating by colony morphology or size. The first 9600 mutants were robotically arrayed in 96-well plates for long-term storage before any phenotypic screening. The remaining 8900 mutants were randomly picked and screened for differentially regulated lux fusions (see below) before selecting 384 mutants to be maintained, which were added to the initial batch of arrayed mutants. In addition, the library is available in the form of an unresolved pool of mutants to permit screening for additional phenotypes. High-throughput inverse PCR and sequencing for insertion-site mapping A variety of methods are available for mapping random transposon insertion sites, ranging from direct cloning of flanking DNA, direct sequencing of genomic DNA with transposon-specific primers (Slesarev et al. 2002), and various PCR methods to amplify DNA flanking the transposon for sequencing (Karlyshev et al. 2000; Geoffroy et al. 2003; Jacobs et al. 2003). We developed a high-throughput inverse PCR protocol that involved the isolation of genomic DNA, digestion with restriction enzymes that cut once within the transposon but numerous times within the genome, and ligation to circularize all linear genomic fragments, followed by PCR using two outward-facing, transposon-specific primers. All genomic DNA samples were NarI digested and processed through the inverse PCR protocol. If the PCR reaction failed, the process was repeated with SstII-digested genomic DNA. Restriction enzymes that cut more frequently in the genome, such as NarI, generate higher success rates for inverse PCR. This is likely due to the smaller average genomic fragment size after digestion, which facilitated circularization during ligation, and ultimately produced smaller PCR products. An initial phase of random transposon mapping was carried out on mutants randomly distributed among the library, and a second phase of transposon mapping was performed on mutants screened for specific phenotypes. PCR products were obtained for -72% of all samples processed through two successive rounds of inverse PCR (3325/4608). All PCR-positive products were purified, sequenced, and mapped to the P. aeruginosa PAO1 genome. Sequencing primers were designed to sequence across the junction of the transposon and flanking genomic DNA where the transposon insertion site corresponded to the first nucleotide after the transposon-specific sequence. A summary of the sequencing and insertion-site mapping results are shown in Table 1.
In total, 2519 transposon insertion sites were mapped to the genome, both within predicted genes and in intergenic regions. Approximately 77% of all insertions were nonredundant (1932/2519), which was defined as insertions >50 bp apart. The exact insertion site was difficult to map for PCR products derived from SstII-digested genomic DNA, due to the proximity of the nested sequencing primer to the transposon junction. Mini-Tn5-lux transposons were mapped to 1284 unique predicted P. aeruginosa ORFs, representing knockouts in nearly 25% of nonessential P. aeruginosa genes (1284/5170) (Jacobs et al. 2003). A database was designed to facilitate searching for available mutants (http://pseudomutant.pseudomonas.com). These mutants will be made freely available to the community through the Pseudomonas Genome Database (http://www.pseudomonas.com). Transposon insertion sites are evenly distributed except for the predicted terminus of replication The distribution of mini-Tn5-lux insertion sites in the PAO1 genome is shown in Figure 1
Interestingly, analyses of nucleotide skews, including GC skew, AT skew, and purine excess indicated that the terminus of the P. aeruginosa genome is located around the 2.5-Mb position (Song et al. 2003; Hallin and Ussery 2004). Since the region between 2 and 3 Mb surrounds the predicted terminus of replication, we therefore propose that the low-insertion site density in this region may be due to the lower average number of targetgene copies in replicating cells. Cationic antimicrobial peptide resistance genes are induced under Mg2+ starvation Approximately 55% of all transposon mutants generated were transcriptional lux fusions (Table 1). To demonstrate the utility of this sensitive, real-time reporter of gene expression, mutants were screened in various growth conditions to identify genes that were differentially regulated. Two-component regulatory systems comprise a major class of regulatory proteins among the 10% of predicted P. aeruginosa ORFs that are annotated as regulatory proteins (Stover et al. 2000); however, few of the 64 two-component regulatory systems in P. aeruginosa have been well studied, and the environmental signals leading to their activation are largely unknown. In P. aeruginosa, the PhoPQ and PmrAB two-component systems are known to respond to Mg2+ limitation and regulate the expression of genes necessary for resistance to cationic antimicrobial peptides and aminoglycosides (Macfarlane et al. 1999, 2000; McPhee et al. 2003). In an attempt to identify genes that are regulated by magnesium limitation and that are potentially members of the PhoPQ or PmrAB regulons, we screened a total of 18,500 randomly picked mutants for lux fusions that were strongly induced or repressed when grown in minimal medium supplemented with 20 μM MgSO4 (limiting) and 2 mM MgSO4 (sufficient). Mutants of interest were identified in a preliminary screen by visualizing the relative luminescence intensities of mid-log cultures grown in these two conditions. Initial phenotypes were then confirmed by quantitative measurement of light production throughout the growth cycle under both conditions. Table 2 lists the mutants with mapped insertion sites that were strongly induced during growth under Mg2+ limitation. The five-gene operon between PA4773 and PA4777 that encodes pmrAB, and the eight-gene operon between PA3552 and PA3559 that encodes a putative LPS modification operon were among the most highly induced operons (Table 2; Fig. 2
Our laboratory previously reported that the pmrAB system was regulated by Mg2+ and was necessary for polymyxin B resistance (McPhee et al. 2003). It was subsequently shown that the pmrAB system regulates the addition of aminoarabinose to the lipid A moiety of P. aeruginosa LPS (Moskowitz et al. 2004). This species of modified LPS has been observed in minimally cultured CF isolates of P. aeruginosa (Ernst et al. 1999), and it is believed that the PA3552–PA3559 operon is responsible for the aminoarabinose modification, as it is homologous to a similar operon in Salmonella typhimurium (Gunn et al. 1998). MIC assays were performed to determine whether the PA3552–PA3559 operon plays a role in resistance to CAPs in P. aeruginosa. Mutations in both the pmrAB and PA3552–PA3559 operons resulted in significant increases in susceptibility to polymyxin B and other cationic antimicrobial peptides such as CP10A and CP11CN, which are improved variants of indolicidin, a cationic peptide from bovine neutrophils (Table 3) (Friedrich et al. 2000; Rozek et al. 2003).
In addition to antibiotic-resistance genes, there were several transport proteins up-regulated under Mg2+ limitation, including a Mg2+-specific transport ATPase protein MgtA and a second P-type ATPase for metal transport (Table 2; Fig. 3A
Screening for differentially regulated genes also led to the identification of a number of genes that were repressed when grown under magnesium limitation (Fig. 3 P. aeruginosa smooth LPS is a heterogeneous mixture of two kinds of chemically and antigenically distinct molecules termed the A and B bands (Rivera et al. 1988). The B band LPS represents a major antigen that determines serological specificity in P. aeruginosa through the nature of the sugar residues in its O-antigen polysaccharide portion. Two genes in the B band O antigen biosynthesis cluster, wpbE and wbpC, were found to be repressed under growth in limiting magnesium (Fig. 3C Phosphate limitation induces phosphate acquisition genes Genes regulated by environmental inorganic phosphate levels comprise the phosphate regulon. The PhoBR two-component system is required for the induction of genes necessary for phosphate acquisition (Filloux et al. 1988). Recent data indicated that the phosphate regulon is induced in P. aeruginosa after interaction with epithelial cells (Frisk et al. 2004). To identify genes that were regulated by phosphate limitation, and thus, potentially members of the PhoBR regulon, we screened a total of 12,000 mutants for lux fusions that were strongly induced when grown in minimal medium with limiting phosphate (0.2 mM). From this screen, we identified phosphate acquisition genes that were previously known to be phosphate regulated, including the major outer membrane phosphate-specific porin OprP (Siehnel et al. 1988) and alkaline phosphatase PhoA (PA3296) (Filloux et al. 1988; Table 4; Fig. 3D
A number of novel phosphate acquisition genes were also identified, including a protein with homology to the Escherichia coli PstS periplasmic-binding protein of a phosphate-specific ABC transporter (PA0688), and a protein with homology to an extracellular nuclease (PA3909) (Table 4, Fig. 3D One interesting phosphate starvation-induced gene was PA4351, which encodes a protein with 50% similarity to an acyltransferase (olsA) involved in ornithine lipid synthesis in Sinorhizobium meliloti (Weissenmayer et al. 2002). Under phosphate-limiting conditions, bacteria can produce alternative phospholipids that replace the phosphate head group with the amino acid ornithine, or other basic amino acids, to produce phospholipids with a net positive charge. Pseudomonas aeruginosa is known to produce a small percentage of ornithine-derived lipids under growth in rich medium, but the biosynthetic genes have not been identified (Kawai et al. 1988). Conclusion We report the construction of a multifunctional mini-Tn5-luxCDABE mutant library in P. aeruginosa PAO1 that is useful for standard phenotypic screening and identifying differentially regulated genes. The utility of generating mutants with chromosomal luxCDABE fusions was illustrated by screening for genes differentially regulated by magnesium and phosphate-limiting conditions. Many of the Mg2+-regulated lux fusions mapped to genes required for resistance to cationic antimicrobial peptides. The database of available mutants has been integrated into the Pseudomonas Genome Database (http://www.pseudomonas.com). There are multiple mutant library projects in P. aeruginosa, with each library constructed with various transposons and in several commonly used strains. A saturating mutagenesis was recently performed in P. aeruginosa PAO1 using a combination of mini-Tn5-phoA and lacZ transposons, which led to the identification of 300–400 candidate essential genes (Jacobs et al. 2003). Mutant libraries have also been constructed in strains PAK (Jacobs et al. 2003) and PA14 (F.M. Ausubel, pers. comm.). Signature-tagged mutagenesis has also been performed to create mutant libraries that permit the identification of genes required for virulence in vivo (Potvin et al. 2003). Each of these mutant libraries has its own assets, but the availability of such a large variety of mutants in multiple P. aeruginosa strains is of major benefit to Pseudomonas researchers and those performing comparative functional genomic analyses with other Pseudomonas species. Methods Mutant construction and transposon-insertion mapping The mini-Tn5-lux transposon was delivered to P. aeruginosa PAO1 by conjugation with the donor strain E. coli S17-1 λ-pir (pUTmini-Tn5-luxCDABE-Tc) (Winson et al. 1998). P. aeruginosa recipient cells were grown at 42°C prior to biparental mating. Mixtures of the donor and recipient (1:2) were incubated on LB agar for 6–8 h at 37°C. To select for P. aeruginosa transconjugants, cells were resuspended in PBS and plated onto large 22 × 22-cm LB agar plates containing 50 μg/mL of tetracycline (Tc) to selectively kill the E. coli donor. Transconjugants were robotically picked into 96-well plates containing 100 μL of LB broth + 50 μg/mL of Tc, grown overnight, and frozen after the addition of DMSO (7% final concentration) for long-term storage at -80°C. A high-throughput inverse PCR protocol was developed for the mapping of transposon sites, in which all steps were performed in a 96-well format with the use of a DNA Engine Tetrad gradient cycler (MJ Research). Cells were harvested from 24-h cultures (1.2 mL), and genomic DNA was isolated using the DNeasy Kit (Qiagen) according to manufacturer's recommendations. Genomic DNA was examined for purity and quantity on 1% agarose-Tris-acetate-EDTA (TAE) gels. For amplication of DNA flanking the left side of the transposon, SstII digestion, ligation, and inverse PCR were performed (SstII-IPCR), while for amplification of the right side of the transposon, NarI digestion, ligation, and inverse PCR (NarI-IPCR) were performed. Alternatively, SphI was used instead of SstII for amplification of the left side of the transposon. These restriction enzymes were chosen because their cut sites are present in the transposon, and they were likely to cut near the site of insertion due to the large number of cut sites in the PAO1 genome. Between 250 and 500 ng of genomic DNA was digested overnight with 2 U of NarI (NEB) or SstII (Invitrogen) (20 μL reaction volume) and heat inactivated at 65°C (SstII) or 85°C (NarI). T4 DNA Ligase (0.5 U) (Invitrogen) and its corresponding buffer was added to the digestion reaction to bring the volume to 25 μL and incubated overnight with temperatures cycling between 10 and 30°C. The ligation product was used as template for an inverse PCR reaction. (See Supplemental information for PCR conditions and primer sequences). The PCR reaction products were run on 1% agarose-TAE gels, and all samples yielding a single major band were selected for clean up with magnetic beads (Agencourt) and sequencing. Alternatively, a semi-random two-step (arbitrary) PCR method to amplify DNA flanking the transposon site was occasionally used as previously described (McPhee et al. 2003). PCR products were sequenced with nested primers at the University of Victoria Sequencing Centre or occasionally in our lab using Big Dye Terminator chemistry (Applied Biosystems) on a Basestation 51 Fragment Analyzer (MJ Research). Transposon insertion sites in the PAO1 genome were determined using an automated process, whereby a PERL script parsed the top scoring BLASTN alignment to each query sequence. The coordinates for each insertion were then used to reference an annotation table of ORFs and intergenic regions. A second PERL script was used to identify transcriptional versus nontranscriptional fusions given the orientation of the gene where the insertion had occurred, the restriction enzyme used in the initial digestion, and the orientation of the transposon relative to the origin of replication in the PAO1 genome. Global gene-expression assays We developed an assay to screen thousands of mini-Tn5-lux mutants for differential expression during growth in various conditions. To identify genes induced or repressed under Mg2+ limitation, bacteria were grown in BM2-glucose minimal medium (Macfarlane et al. 2000) containing 20 μM (low) or 2 mM (high) MgSO4. To identify genes induced or repressed under PO 3-4 limitation, bacteria were grown in a defined phosphate minimal medium (Hancock et al. 1982) containing 200 μM (low) or 1 mM (high) PO 3-4. A 48-pin replicator stamp was used to subculture overnight LB cultures into the left and right half of 96-well plates containing “low” and “high” medium conditions, respectively. After growth for 4–6 h, the luminescence was observed using a ChemiGenius2 Bio-Imaging System (Syngene). From the preliminary screen, mutants were selected that were either strongly induced or repressed and were retested by quantitatively measuring luminescence (RLU) using a SPECTRAFluorPlus luminometer (Tecan) throughout growth. Luminescence was corrected for growth by simultaneously monitoring the absorbance at 620 nm. Antibiotic susceptibility assays The minimal inhibitory concentration (MIC) of various cationic antimicrobial peptides was determined using a modified microtitre broth dilution technique as previously described (Amsterdam 1991; Wu and Hancock 1999). Polypropylene plates were used to prevent aggregation of peptides on polystyrene and artificially high MICs. Susceptibility was assayed in BM2-glucose minimal medium containing 20 μM MgSO4. Growth was scored after 24-h incubation at 37°C. Acknowledgments S.L. was supported by a Canadian Cystic Fibrosis Foundation (CCFF) fellowship. J.B.M. was supported by a CCFF studentship. F.S.L.B. was a Michael Smith Foundation for Health Research Scholar. R.E.W.H. held a Canada Research Chair. We thank Glenn A. Cooper, Ross Gibbs, Marianne Beetz-Sargent, and Ben Koop for DNA sequencing performed at the Genome BC Sequencing Centre of the University of Victoria. Funding for this research was from the Functional Pathogenomics of Mucosal Immunity program supported by Genome Prairie and Genome BC with ancillary support from Inimex Pharmaceuticals Inc, the Canadian Institutes of Health Research (CIHR) and from the CCFF. Notes Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.3513905. Footnotes [Supplemental information is available online at www.genome.org.] References
Web site references
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8):4678-83.
[Proc Natl Acad Sci U S A. 2003]J Bacteriol. 2004 Aug; 186(15):4921-30.
[J Bacteriol. 2004]Science. 1999 Dec 10; 286(5447):2165-9.
[Science. 1999]Genome Res. 2003 Mar; 13(3):391-8.
[Genome Res. 2003]Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14339-44.
[Proc Natl Acad Sci U S A. 2003]Microbiol Rev. 1996 Sep; 60(3):539-74.
[Microbiol Rev. 1996]Clin Infect Dis. 1998 Aug; 27 Suppl 1():S117-24.
[Clin Infect Dis. 1998]Drug Resist Updat. 2000 Aug; 3(4):247-255.
[Drug Resist Updat. 2000]J Bacteriol. 2001 Dec; 183(24):7126-34.
[J Bacteriol. 2001]Nature. 2000 Aug 31; 406(6799):959-64.
[Nature. 2000]Bioinformatics. 2003 Aug 12; 19(12):1457-60.
[Bioinformatics. 2003]FEMS Microbiol Lett. 1998 Jun 15; 163(2):193-202.
[FEMS Microbiol Lett. 1998]Proc Natl Acad Sci U S A. 2002 Apr 2; 99(7):4644-9.
[Proc Natl Acad Sci U S A. 2002]Biotechniques. 2000 Jun; 28(6):1078, 1080, 1082.
[Biotechniques. 2000]Genome Res. 2003 Mar; 13(3):391-8.
[Genome Res. 2003]Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14339-44.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14339-44.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14339-44.
[Proc Natl Acad Sci U S A. 2003]J Bacteriol. 2004 Aug; 186(15):4921-30.
[J Bacteriol. 2004]BMC Genomics. 2003 May 5; 4(1):17.
[BMC Genomics. 2003]Bioinformatics. 2004 Dec 12; 20(18):3682-6.
[Bioinformatics. 2004]Nature. 2000 Aug 31; 406(6799):959-64.
[Nature. 2000]Mol Microbiol. 1999 Oct; 34(2):305-16.
[Mol Microbiol. 1999]Microbiology. 2000 Oct; 146 ( Pt 10)():2543-54.
[Microbiology. 2000]Mol Microbiol. 2003 Oct; 50(1):205-17.
[Mol Microbiol. 2003]Mol Microbiol. 2003 Oct; 50(1):205-17.
[Mol Microbiol. 2003]J Bacteriol. 2004 Jan; 186(2):575-9.
[J Bacteriol. 2004]Science. 1999 Nov 19; 286(5444):1561-5.
[Science. 1999]Mol Microbiol. 1998 Mar; 27(6):1171-82.
[Mol Microbiol. 1998]Antimicrob Agents Chemother. 2000 Aug; 44(8):2086-92.
[Antimicrob Agents Chemother. 2000]J Bacteriol. 1988 Feb; 170(2):512-21.
[J Bacteriol. 1988]Mol Gen Genet. 1988 Jun; 212(3):510-3.
[Mol Gen Genet. 1988]Infect Immun. 2004 Sep; 72(9):5433-8.
[Infect Immun. 2004]J Bacteriol. 1988 May; 170(5):2312-8.
[J Bacteriol. 1988]Mol Microbiol. 2002 Aug; 45(3):721-33.
[Mol Microbiol. 2002]Eur J Biochem. 1988 Aug 15; 175(3):633-41.
[Eur J Biochem. 1988]Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14339-44.
[Proc Natl Acad Sci U S A. 2003]Environ Microbiol. 2003 Dec; 5(12):1294-308.
[Environ Microbiol. 2003]FEMS Microbiol Lett. 1998 Jun 15; 163(2):193-202.
[FEMS Microbiol Lett. 1998]Mol Microbiol. 2003 Oct; 50(1):205-17.
[Mol Microbiol. 2003]Microbiology. 2000 Oct; 146 ( Pt 10)():2543-54.
[Microbiology. 2000]J Bacteriol. 1982 May; 150(2):730-8.
[J Bacteriol. 1982]J Biol Chem. 1999 Jan 1; 274(1):29-35.
[J Biol Chem. 1999]Mol Microbiol. 2003 Oct; 50(1):205-17.
[Mol Microbiol. 2003]